当前位置:首页 - 行情中心 - 景峰医药(000908) - 财务分析 - 利润表

景峰医药

(000908)

  

流通市值:26.81亿  总市值:32.90亿
流通股本:7.17亿   总股本:8.80亿

利润表

按照会计年度查询:
报告期2020-03-312019-12-312019-09-302019-06-30
一、营业总收入307,774,671.771,344,029,111.241,033,105,103.57689,240,750.55
营业收入307,774,671.771,344,029,111.241,033,105,103.57689,240,750.55
二、营业总成本309,469,615.892,023,917,711.381,258,019,277.96688,430,297.16
营业成本123,850,262.22537,065,460.46358,611,388.04239,599,108.3
营业税金及附加2,353,736.7319,434,482.3511,986,517.879,335,340.9
销售费用76,135,370.17906,506,732.75532,568,592.77213,324,178.09
管理费用53,518,001.29271,101,966.03186,594,126.95126,856,173.63
财务费用27,652,826.2198,509,307.3966,887,837.0644,562,575.89
资产减值损失---306,039,454.82----
三、其他经营收益-118,763.71859,482.081,149,422.87614,272.87
允许价值变动净收益--------
投资净收益-217,332.5166,464,712.3477,556,381.6371,778,635.33
联营、合营企业投资收益-361,245.65-12,236,517.9-454,892.25-7,176,784.81
汇兑净收益--------
四、营业利润-1,664,849.07-908,394,374.69-143,376,745.9370,266,495.04
营业外收入145,578.07952,479.35630,062.13588,694.32
营业外支出1,012,816.9512,328,645.923,874,433.891,992,945.16
非流动资产处置净损失--------
五、利润总额-2,532,087.95-919,770,541.26-146,621,117.6968,862,244.2
所得税4,904,920.41,781,092.8317,869,701.0516,217,452.29
未确认的投资损失--------
六、净利润(百万元)1.38-882.81-142.9463.03
少数股东损益-8,818,273.01-38,745,165.44-21,547,392.85-10,389,695.67
归属于母公司股东的净利润1,381,264.66-882,806,468.65-142,943,425.8963,034,487.58
七、每股收益0-1-0.160.07
基本每股收益0-1-0.160.07
稀释每股收益0-1-0.160.07
TOP↑